POLYMORPHISM OF PREDISPOSITION GENES IN CHRONIC OBSTRUCTIVE PULMONARY DISEASE AND ARTERIAL HYPERTENSION IN GERIATRIC PATIENTS

Aim. To assess the associations between predisposition genes (TGF-p1, HHIP, IL6R, SOD3, and CHRNA3), in relation to peripheral vascular structure and function, endothelial dysfunction, and cytokine status, in geriatric patients with chronic obstructive pulmonary disease (COPD) and arterial hypertension (AH). Material and methods. In total, 154 geriatric patients with either isolated AH or the combination of AH and COPD underwent clinical, functional, laboratory, ultrasound, and cytogenetic examination.

Results. The key associations between predisposition genes, in relation to peripheral vascular structure and function, endothelial dysfunction, and cytokine status, were identified in geriatric patients with COPD and AH who received short- or long-acting inhaled M-cholinolytics and steroids combined with perindopril monotherapy (10 mg/day; Prestarium, Servier Laboratories, France).

Conclusion. The combination of COPD and AH was characterised by significantly different distribution of genotypes and alleles (TGFB1 gene rs1804470 allele and HHIP gene rs1828591 allele), in relation to geriatric age. Patients with the COPD and AH combination had more severe endothelial dysfunction, cytokine activation, and disturbed structure and function of peripheral vessels (distal-proximal type). There were significant differences in peripheral vascular remodelling parameters among elderly vs. very elderly patients with COPD and AH.

1. Dvoretsky LI. Keeping elderly COPD. M.: Letter, 2005: 27-8. Russian (Дворецкий Л. И. Ведение пожилого больного ХОБЛ. М.: Литера, 2005: 27-8).

2. Mathers CD, Loncar D. Projections of global mortality and burden of disease from 2002 to 2030. PLoS Med 2006; 3: e442.

3. Avdeev SN. Pulmonary hyperinflation in patients with COPD. Consilium Med. 2006; 3: 75-80. Russian (Авдеев С. Н. Легочная гиперинфляция у больных ХОБЛ. Consilium Med. 2006; 3: 75-80).

4. Shpagina LA, Gerasimenko ON, Shpagin IS, et al. Endothelial dysfunction and vascular remodeling in hypertension in combination with chronic obstructive pulmonary disease: a new therapeutic target. Pulmonology 2009; 3: 47-54. Russian (Шпагина Л.А, Герасименко О.Н, Шпагин И. С.и др. Эндотелиальная дисфункция и ремоделирование сосудов при артериальной гипертензии в сочетании с хронической обструктивной болезнью легких: новые терапевтические мишени. Пульмонология 2009; 3: 47-54).

5. Zhang L, Chang WW, Ding H, et al. Transforming growth factor-p1 polymorphisms and chronic obstructive pulmonary disease: a meta-analysis. Int J Tuberc Lung Dis. 2011 Oct;15 (10):1301-7Xi B, Wang Q, Pan H. Transforming growth factor-p1 gene +869T/C, but not +915G/C polymorphism is associated with essential hypertension in a Chinese patient cohort. Mol Biol Rep. 2012 May; 39 (5): 6107-12.

6. Van Durme YM, Lahousse L, Verhamme KM, et al. Mendelian randomization study of interleukin-6 in chronic obstructive pulmonary disease. Respiration. 2011; 82 (6):530-8.

7. Korytina GF. Genetic analysis of hereditary predisposition to chronic respiratory diseases: Avtoref.dis. ... Doctor. biol. Sciences. Ufa, 2012. Russian (Корытина Г. Ф. Mолекулярно- генетический анализ наследственной предрасположенности к хроническим заболеваниям органов дыхания: Автореф.дис. ... докт. биол. наук. Уфа; 2012).

8. Ferrari R. angiotensin-converting enzyme inhibition in cardiovascular disease: evidence with perindopril. Expert Rev. Cardiovasc. Ther. 2005; 3: 15-29.

9. Castaldi PJ, Cho MH, Cohn M, et al. The COPD genetic association compendium: a comprehensive online database of COPD genetic associations. Hum Mol Genet. 2010 Feb 1; 19 (3): 526-34.

10. Pillai SG, Ge D, Zhu G, et ICGN Investigators. A genome-wide association study in chronic obstructive pulmonary disease (COPD): identification of two major susceptibility loci. PLoS Genet. 2009 Mar; 5 (3).

11. Van Durme YM, Eijgelsheim M, Joos GF, et al. Hedgehog-interacting protein is a COPD susceptibility gene: the Rotterdam Study Eur Respir J. 2010 Jul; 36 (1): 89-95.

12. Sorheim IC, DeMeo DL, Washko G, et al. Polymorphisms in the superoxide dismutase-3 gene are associated with emphysema in COPD. COPD. 2010 Aug; 7 (4): 262-8.

13. Korytina GF, Akhmadishina LZ, Tselousova OS, et al. Analysis of gene polymorphic variants of antioxidant enzymes and their relationship with the development of chronic obstructive pulmonary disease among residents of Bashkortostan. Genetics 2009; 45, 7: 967-76. Russian (Корытина Г. Ф., Ахмадишина Л. З., Целоусова О. С. и др. Анализ полиморф¬ных вариантов генов ферментов антиоксидантной защиты и их связь с развитием хронической обструктивной болезни легких у жителей республики Башкортостан. Генетика 2009; 45, 7: 967-76).

14. Ferreira MA, Matheson MC, Duffy DL, et al. Identification of IL6R and chromosome 11q13.5 as risk loci for asthma. Lancet. 2011 Sep 10; 378 (9795): 1006-14.

15. Zhang J, Summah H, Zhu YG, et al. Nicotinic acetylcholine receptor variants associated with susceptibility to chronic obstructive pulmonary disease: a meta-analysis. Respir Res. 2011 Dec 17; 12: 158.

16. Budulac SE, Vonk JM, Postma DS, et al. Nicotinic acetylcholine receptor variants are related to smoking habits, but not directly to COPD. PLoS One. 2012; 7 (3): e33386.